Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sculpher

Showing results (41-50 of 174) with videos related to

Pageof 18
Sort By:
Health Economics|December 10, 2014
Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?Karl Claxton, Mark Sculpher, Stephen Palmer, et al.
Health Economics|October 5, 2017
Social value and individual choice: The value of a choice-based decision-making process in a collectively funded health systemManuel Antonio Espinoza, Andrea Manca, Karl Claxton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 6, 2007
Efficiency, equity, and budgetary policies: informing decisions using mathematical programmingDavid M Epstein, Zaid Chalabi, Karl Claxton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 21, 2007
Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modelingAndrea Manca, Paul C Lambert, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
The Use of MCDA in HTA: Great Potential, but More Effort NeededKevin D Marsh, Mark Sculpher, J Jaime Caro, et al.
Pharmacoeconomics|April 12, 2006
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessmentZoë Philips, Laura Bojke, Mark Sculpher, et al.
BMJ (Clinical Research Ed.)|November 30, 2014
Reforming the cancer drug fundMartin Buxton, Louise Longworth, James Raftery, et al.
Pharmacoeconomics|April 2, 2026
What is the Value of Developing an HTA Process?Peter Murphy, Simon Walker, Septiara Putri, et al.
Applied Health Economics and Health Policy|May 18, 2019
Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision MakersSimon Walker, Susan Griffin, Miqdad Asaria, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 30, 2005
Estimating utility data from clinical indicators for patients with stable anginaLouise Longworth, Martin J Buxton, Mark Sculpher, et al.
Pageof 18

Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
Health Economics|December 10, 2014
Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?Karl Claxton, Mark Sculpher, Stephen Palmer, et al.
Health Economics|October 5, 2017
Social value and individual choice: The value of a choice-based decision-making process in a collectively funded health systemManuel Antonio Espinoza, Andrea Manca, Karl Claxton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 6, 2007
Efficiency, equity, and budgetary policies: informing decisions using mathematical programmingDavid M Epstein, Zaid Chalabi, Karl Claxton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 21, 2007
Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modelingAndrea Manca, Paul C Lambert, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
The Use of MCDA in HTA: Great Potential, but More Effort NeededKevin D Marsh, Mark Sculpher, J Jaime Caro, et al.
Pharmacoeconomics|April 12, 2006
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessmentZoë Philips, Laura Bojke, Mark Sculpher, et al.
BMJ (Clinical Research Ed.)|November 30, 2014
Reforming the cancer drug fundMartin Buxton, Louise Longworth, James Raftery, et al.
Pharmacoeconomics|April 2, 2026
What is the Value of Developing an HTA Process?Peter Murphy, Simon Walker, Septiara Putri, et al.
Applied Health Economics and Health Policy|May 18, 2019
Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision MakersSimon Walker, Susan Griffin, Miqdad Asaria, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 30, 2005
Estimating utility data from clinical indicators for patients with stable anginaLouise Longworth, Martin J Buxton, Mark Sculpher, et al.
Pageof 18